FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing - FDA Press Releases

FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing

from Food and Drug Administration--Press Releases http://ift.tt/2EzkVXY
via IFTTT